Updated: January 26, 2026
How Does Pentasa XR Work? Mechanism of Action Explained in Plain English
Author
Peter Daggett

Summarize with AI
Pentasa XR works by releasing mesalamine directly in the GI tract to reduce inflammation. Here's a plain-English explanation of exactly how and why it works for UC.
If you take Pentasa XR for ulcerative colitis, you've probably wondered: how does this actually work? Understanding your medication can help you take it correctly, recognize warning signs, and have better conversations with your doctor. Here's a clear, jargon-free explanation of how Pentasa XR works in your body.
What Is Ulcerative Colitis and Why Does It Need Treatment?
Ulcerative colitis (UC) is a chronic inflammatory bowel disease (IBD) that causes inflammation and ulcers in the lining of the colon (large intestine). In UC, the immune system mistakenly attacks the cells lining the bowel, triggering an overproduction of inflammatory chemicals — called prostaglandins and leukotrienes — that cause the tissue damage, pain, diarrhea, and bleeding that characterize a UC flare.
The goal of treatment is to reduce this inflammation — either by calming the immune system (biologics and immunosuppressants) or by targeting the inflammation directly in the gut lining (mesalamine). Pentasa XR takes the second approach.
What Is Mesalamine and How Does It Work?
Mesalamine (the active ingredient in Pentasa XR) is chemically known as 5-aminosalicylic acid, or 5-ASA. It's an anti-inflammatory agent that works locally — meaning it acts directly on the cells lining the gastrointestinal tract, rather than being absorbed into the bloodstream and affecting your whole body.
The precise mechanism isn't fully understood, but research points to several key actions:
- Blocking cyclooxygenase (COX): Mesalamine inhibits COX enzymes, which are responsible for producing prostaglandins — the inflammatory signaling molecules that contribute to the pain and swelling of a UC flare.
- Inhibiting lipoxygenase (LOX) pathways: Mesalamine also blocks lipoxygenase pathways, which produce leukotrienes — another class of inflammatory chemicals that are elevated in IBD.
- Direct anti-inflammatory effect on mucosal cells: Mesalamine reduces the production of arachidonic acid metabolites (the building blocks of both prostaglandins and leukotrienes) in the mucosal lining of the colon.
How Does the 'Extended-Release' Technology Work?
Here's what makes Pentasa XR physically unique compared to other mesalamine products: the 'extended-release' refers to a very specific delivery system.
Inside each Pentasa XR capsule are thousands of tiny microspheres — think of them as miniature capsules within the capsule. Each microsphere is coated with ethylcellulose, a material that doesn't dissolve in stomach acid. Instead of releasing all the drug at once, these microspheres release mesalamine gradually as the capsule travels through the digestive tract. The release begins as early as the duodenum (the first part of the small intestine, just past the stomach) and continues through the jejunum, ileum, and into the colon.
This is different from most other mesalamine brands. Lialda and Apriso, for example, use pH-dependent coatings that only dissolve when they reach the higher-pH (less acidic) environment of the colon. Pentasa XR's ethylcellulose system doesn't depend on pH — it works through a slow, physical release mechanism that begins earlier in the digestive journey.
Where Does Pentasa XR Work in the Body?
Pentasa XR releases mesalamine continuously throughout the entire GI tract:
- Duodenum: Release begins shortly after swallowing
- Jejunum and Ileum (small intestine): Continues releasing throughout the small bowel
- Colon (large intestine): Continues releasing in the colon where most UC activity occurs
Because it reaches both the small intestine and the colon, Pentasa XR is particularly useful for patients with UC that extends into the small bowel or for off-label use in Crohn's disease with small bowel involvement.
Why Does Pentasa XR Have to Be Taken Four Times a Day?
Because the drug works locally (at the site of inflammation in the gut) rather than systemically (through the bloodstream), it needs to be present at the right place at the right time. The four-times-daily dosing schedule maintains a continuous level of mesalamine throughout the GI tract throughout the day. Unlike once-daily formulations that deliver a single large dose, Pentasa XR's multiple daily doses work in concert with its extended-release microspheres to keep mesalamine at therapeutic levels from morning to night.
For more on Pentasa XR including its approved uses and dosage, see: What is Pentasa XR?. And if you're having trouble finding it in stock, medfinder.com can help.
Frequently Asked Questions
Mesalamine works locally in the GI tract by inhibiting cyclooxygenase (COX) enzymes and lipoxygenase (LOX) pathways, which reduces the production of prostaglandins and leukotrienes — the inflammatory chemicals responsible for the pain, diarrhea, and bleeding in a UC flare. It acts directly on the mucosal lining rather than systemically throughout the body.
Pentasa XR uses ethylcellulose-coated microspheres that release mesalamine gradually through physical diffusion, not through pH-triggered dissolution. This allows the drug to begin releasing in the duodenum (first part of the small intestine) and continue throughout the jejunum, ileum, and colon — making it unique among oral mesalamine products.
Only partially. Pentasa XR is designed to work locally in the GI tract. Some mesalamine is absorbed into the bloodstream, but the majority exerts its therapeutic effect directly on the colon lining. The portion absorbed is primarily metabolized to N-acetyl-5-aminosalicylic acid and excreted in the urine.
Because mesalamine works locally in the gut rather than through systemic absorption, it needs to be present at the site of inflammation continuously. The four-times-daily schedule maintains consistent drug concentrations throughout the GI tract throughout the day. Other mesalamine brands that deliver larger single doses may achieve once-daily dosing through different release mechanisms.
Medfinder Editorial Standards
Medfinder's mission is to ensure every patient gets access to the medications they need. We are committed to providing trustworthy, evidence-based information to help you make informed health decisions.
Read our editorial standardsPatients searching for Pentasa XR also looked for:
More about Pentasa XR
35,181 have already found their meds with Medfinder.
Start your search today.





